{"filing":{"accession_number":"0001493152-26-024760","cik":"0000946644","ticker":"AIM","company_name":"AIM ImmunoTech Inc.","form":"8-K","filing_date":"2026-05-21","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/946644/000149315226024760/form8-k.htm"},"events":[{"id":9521,"run_id":8351,"accession_number":"0001493152-26-024760","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"AIM ImmunoTech completed an unregistered private placement of Common Warrants and Placement Agent Warrants under Section 4(a)(2) and Rule 506, with pricing announced on May 20, 2026. The offering included a Securities Purchase Agreement and underlying shares, representing a dilutive equity issuance to accredited investors that materially affects shareholder ownership and capital structure.","company_name":"AIM ImmunoTech Inc.","ticker":"AIM","filing_date":"2026-05-21","form":"8-K","submitted_at":null,"items":[{"id":1178,"accession_number":"0001493152-26-024760","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 discloses an unregistered private placement of Common Warrants and Placement Agent Warrants under Section 4(a)(2) and Rule 506, with underlying Common Warrant Shares and shares underlying the Placement Agent Warrants. This is a classic dilutive equity issuance to accredited investors that would materially affect shareholder ownership and is a strong signal of capital-raising activity typical of smaller-cap issuers.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T03:01:46.870333+00:00","company_name":"","ticker":null,"filing_date":""},{"id":1179,"accession_number":"0001493152-26-024760","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The filing discloses pricing of securities offerings with exhibits including a Securities Purchase Agreement, Common Warrants, and Placement Agent Warrants dated May 20, 2026. The press release announcement of \"the pricing of the Offerings\" combined with warrant issuances and the securities purchase agreement structure indicates a dilutive equity issuance, likely a private placement or PIPE transaction. This is material to investors as it affects share dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T03:01:46.870333+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1178,"accession_number":"0001493152-26-024760","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 discloses an unregistered private placement of Common Warrants and Placement Agent Warrants under Section 4(a)(2) and Rule 506, with underlying Common Warrant Shares and shares underlying the Placement Agent Warrants. This is a classic dilutive equity issuance to accredited investors that would materially affect shareholder ownership and is a strong signal of capital-raising activity typical of smaller-cap issuers.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T03:01:46.870333+00:00","company_name":"AIM ImmunoTech Inc.","ticker":"AIM","filing_date":"2026-05-21"},{"id":1179,"accession_number":"0001493152-26-024760","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The filing discloses pricing of securities offerings with exhibits including a Securities Purchase Agreement, Common Warrants, and Placement Agent Warrants dated May 20, 2026. The press release announcement of \"the pricing of the Offerings\" combined with warrant issuances and the securities purchase agreement structure indicates a dilutive equity issuance, likely a private placement or PIPE transaction. This is material to investors as it affects share dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T03:01:46.870333+00:00","company_name":"AIM ImmunoTech Inc.","ticker":"AIM","filing_date":"2026-05-21"}]}